The Forum for Collaborative HIV Research - HCV Drug Resistance Slide Set

The Forum has Moved

HIV Forum joins University of California, Berkeley School of Public Health
Two leading institutions in public health and health policy are joining forces to accelerate the nation's progress in fighting HIV/AIDS, hepatitis C and tuberculosis in Washington - the Forum for Collaborative HIV Research and the University of California, Berkeley, School of Public Health. Click here to read the full press release.

UPDATE Please click here for our new contact information

Updates on Routine HIV Testing in the U.S.

Keep up-to-date with the LATEST news and publications on routine HIV testing in the United States since the 2008 National Summit on HIV Diagnosis, Prevention, and Access to Care.

Click here to read more.

Announcements

Scientists, Advocates Call for Better Methods to Evaluate Increased Risk of CVD

JUL 19-10 Scientists, HIV Advocates Call for Better Methods to Evaluate the Increased Risk of Cardiovascular Disease in Persons with HIV. Two-Fold Increase in Risk May Be Directly Linked to HIV. Click here to read the press release.

HIV Forum joins University of California, Berkeley School of Public Health

JUN 24-10 Two leading institutions in public health and health policy are joining forces to accelerate the nation's progress in fighting HIV/AIDS, hepatitis C and tuberculosis in Washington - the Forum for Collaborative HIV Research and the University of California, Berkeley, School of Public Health. Click here to read the full press release.

Public Forum on CVD Risk and HIV

Satellite Symposium on CVD Risk and HIV

JUN-16-10 Please join the Forum for Collaborative HIV Research for a satellite symposium at the International AIDS Conference in Vienna, Austria, on July 18th, 2010, from 1:30 to 3:30pm in Session Room 4.

Taking Charge of the HIV Epidemic: National HIV Testing Day Webcast

id_10_22699a_hiv_webcast_320x240_banner_060910

UPDATE: JUN 10-10 View the archived webcast by clicking here

Developing and Evaluating Comprehensive HIV Infection Control Strategies: Issues and Challenges

MAY 25-10 See the recent article published in CID here

Reception at the 2010 International AIDS Conference in Vienna

MAY 20-10 Click here for information on a reception sponsored by US NGOs & Civil Society Organizations for our colleagues around the world as a welcome to the 2012 International AIDS Conference to be held in Washington DC

News

Forum Highlights

Follow the HIV Forum on

HCV Drug Resistance Slide Set

Recognizing the need for education regarding HCV drug resistance, the Forum for Collaborative HIV Research's HCV Drug Development Advisory Group (academicians, clinicians, researchers and patient advocates) have contributed to a slide deck explaining resistance in HCV, its consequences as well as its mitigation. The slide deck explains important drug resistance concepts in HCV, including:

how resistance can arise before, during and after stopping therapy;
the mechanism of action of direct acting antivirals (DAAs) and their effects on viral kinetics and the possibility of cure;
how mutations lead to changes which makes the virus resistant to DAAs;
viral, drug and patient factors that influence treatment outcomes.

This educational slide deck is intended for use by a diverse audience ranging from health care providers involved with evaluating, diagnosing and treating HCV, HCV patients who want to learn about the disease and treatment options, and HCV advocates in the community who may use the slides in their education outreach efforts.

Click here to view the deck in PowerPoint format.

For more information, please contact Nina Mani, nmani@hivforum.org